|
|
| Research article summary (published 30 Jul 2005): |
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
Full Abstract
INTRODUCTION: We sought to examine the relationship between C-reactive protein (CRP) and clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease (IBD). METHODS: All IBD patients at our institution between January 2002 and August 2003 who had a CRP, colonoscopy, and either small bowel follow-through (SBFT) or CT enterography (CTE) performed within 14 days were identified. Clinical activity was assessed retrospectively through review of the medical record. Logistic regression was used in Crohn's disease (CD) patients to estimate the odds ratio (OR) with 95% confidence intervals for an elevated CRP. Associations were assessed using Fisher exact test in ulcerative colitis (UC) patients due to small sample size. RESULTS: One-hundred four CD patients (46% males) and 43 UC and indeterminate colitis patients (44% males) were identified. In CD patients, moderate-severe clinical activity (OR, 4.5; 95% CI, 1.1-18.3), active disease at colonoscopy (OR, 3.5; 95% CI, 1.4-8.9), and histologically severe inflammation (OR, 10.6; 95% CI; 1.1-104) were all significantly associated with CRP elevation. Abnormal small bowel radiographic imaging was not significantly associated with CRP elevation. In UC patients, CRP elevation was significantly associated with severe clinical activity, elevation in sedimentation rate, anemia, hypoalbuminemia, and active disease at ileocolonoscopy, but not with histologic inflammation. CONCLUSIONS: CRP elevation in IBD patients is associated with clinical disease activity, endoscopic inflammation, severely active histologic inflammation (in CD patients), and several other biomarkers of inflammation, but not with radiographic activity.
Author information
Author/s: Solem, Craig A (CA); Loftus, Edward V (EV); Tremaine, William J (WJ); Harmsen, William S (WS); Zinsmeister, Alan R (AR); Sandborn, William J (WJ);
Affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Journal and publication information
Publication Type: Comparative Study; Journal Article
Journal: Inflammatory bowel diseases (Inflamm Bowel Dis), published in United States. (Language: eng)
Reference: 2005-Aug; vol 11 (issue 8) : pp 707-12
Dates: Created 2005/07/26; Completed 2005/10/18; Revised 2006/11/15;
PMID: 16043984, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease.
30 Dec 2003 - B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
29 Jun 2001 - Immunological tests to monitor inflammatory bowel disease--have they delivered yet?
27 Feb 1998 - C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
17 Jun 2008 - Serologic testing for inflammatory bowel disease.
30 Mar 1999 - Serologic markers in inflammatory bowel disease.
6 Dec 2005 - Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD.
28 Feb 2004 - Resistin is an inflammatory marker of inflammatory bowel disease in humans.
29 Nov 2007 - Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
30 Aug 2004 - Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel disease.
30 Jul 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.